CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4/A Exercise or conversion Director acquired 1,030 shares (option exercise)
- 4/A Exercise or conversion Director acquired 47,999 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,211 shares (option exercise)
- 4 Exercise or conversion Chief Executive Officer acquired 18,333 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale General Counsel sold 1,636 shares at $10.12 ($16,556)
- 4 Open-market sale Chief Medical Officer sold 1,900 shares at $10.12 ($19,228)
- 4 Exercise or conversion Chief Medical Officer acquired 122,677 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 258 shares at $11.85 ($3,057)
- 4 Exercise or conversion Director acquired 47,999 shares (option exercise)
- 4 Exercise or conversion Director acquired 160,000 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 3,241 shares (option exercise)
- 4 Open-market sale General Counsel sold 3,606 shares at $7.21 ($25,999)
Page 5 of 12 · 233 filings